Pressure On Hysterectomy Procedures Challenges Intuitive’s Financials
This article was originally published in The Gray Sheet
Executive Summary
The robotic surgical instrument company attributes the decline in capital equipment sales to disappointing growth in benign gynecology procedures performed in the U.S. with the firm’s flagship da Vinci robot.
You may also be interested in...
Regulatory News In Brief
IMDRF releases three new proposed guidance documents. FDA is accepting comments on its plans to accept electronic submissions for device recalls. More regulatory news.
News In Brief
Caution on robotic surgery from Ob/Gyn group. FDA gets closer to gaining access to most of fiscal 2013 user fees. More news.
Laparoscopic Hysterectomy Is Cheaper Than Robotic Version With Similar Results
Large study questions the cost-effectiveness of robotic hysterectomy for benign gynecologic condition.